Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics

Trending on Bing

Iran’s new supreme leader
Launches recovery fund
Images of suspect released
Apologizes for airing old clip
Settle patent dispute
US orders diplomats to leave
Arnold seeks playoff delay
State trooper shot in PA
Jalen Smith pleads guilty
NATO intercepts missile
Bluesky CEO steps down
Raiders acquiring Johnson?
Alexander Butterfield dies
Prosecutors to drop charge
Dolphins to release QB
OSU’s president resigns
Trio of lawyers disqualified
Agrees to 3-yr deal with Rams
7th US service member dies
Istanbul’s mayor faces trial
Fire near Glasgow Central
Reaches settlement with DOJ
SCOTUS to hear Guam case
Rolls out women‑only rides
Launch military drill
Parliament extends term
To lead Simon & Schuster
Rep. Kevin Kiley exits GOP
Anthropic sues Trump admin
Belgium synagogue explosion
Raw oysters, clams recalled
Phillips agrees to 4-yr deal?
Indonesia landfill collapse
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Hims & Hers shares surge

Digest more
 · 14h
Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

Continue reading

 · 6h
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
 · 10h · on MSN
Novo Nordisk to sell weight-loss drugs through Hims & Hers
10hon MSN
Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform
Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a ...
28d
Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill
Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss pill Wegovy.
24/7 Wall St.
2d
Hims & Hers Surprise Rescue: Stock Explodes 40% on GLP-1 Truce
In a dramatic reversal of fortune, Hims & Hers Health (NYSE:HIMS) has been rescued by the very company that nearly sank it. Novo Nordisk (NYSE:NVO), which sued the telehealth provider just last month ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
  • Privacy
  • Terms